POSTOPERATIVE PAIN MANAGEMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Post-operative Pain Management Market - Overview Global Post-operative Pain Management Market Post-operative pain includes all types of acute pain that occur due to injuries and resolve in an appropriate healing period. Such pain often responds to analgesic medication, as well as a treatment of the precipitating cause. Post-operative pain could also trigger cardiovascular, respiratory, endocrine, metabolic dysfunctions. Post-operative pain treatment is thus aimed at mobilizing the patient as early as possible. It allows the patient to drink and eat and to be able to deep breathe and cough. If the patients are not made to undergo a proper post-operative pain treatment, they can potentially develop cardiac problems, chest infections, depression, wound-induced infection, and hypoxia. Post-operative pain treatment has evolved over recent years, with different concepts of how drugs affect the body when used in specific combinations.
Opioids and non-steroidal anti-inflammatory drugs are expected to contribute to a major market share, in terms of value, in the global post-operative pain management market. Opioids are substances that act on the opioid receptors to produce morphine-like effects. They are most often used to relieve pain. Whereas, non-steroidal anti-inflammatory drugs are used to treat pain, inflammation, and fever. Browse Research Reports: https://www.coherentmarketinsights.com/ongoinginsight/postoperative-pain-management-market-154 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Prevalent Scenario of the post-operative pain management market Increasing number of surgical procedure is expected to act as a value-driver to the global postoperative pain management market. As per the World Bank, in the U.S. there were 30,537 number of surgical procedures performed in 2012. As per National Center for Health Statistics, of overall surgical procedures half of the procedure requires postoperative pain medication which provides high opportunity for manufacturers. As per Centers for Disease Control and Prevention (CDC), every year there are around 41 million visits in emergency department due to trauma. Around 450,000 burns require medical attention annually. Increase in trauma cases to act as a fuel to the overall growth of postoperative pain management market. Some postoperative pain drugs include side effects. Despite the many advancement in postoperative pain management, opioids are still considered as the mainstay pain therapy in many settings. All opioids have significant side effects that are limiting its use. One of the major side-effects associated with the use of opioid is respiratory depression. According to CDC, the prescription opioid overdose killed around 16,500 people in 2015. The increasing cases of drug overdoses and side-effects associated with postoperative pain drugs is expected to act as a restraint to the overall market. Increasing geriatric population in emerging economies and increasing prevalent cases of acute diseases is expected to fuel growth of the market. Increasing patient awareness regarding surgeries and operations and the growing research related to pain management is expected to create high opportunity for pain relieving drug manufacturers. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/154 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Global Post-operative Pain Management Market – Key Players The global postoperative pain management market is highly fragmented, owing to the participation of many established and emerging players, such as Bayer AG, DURECT Corporation, Pfizer Inc., BTG International Ltd, Novartis AG, and A.P. Pharma, Inc. Key Developments These market contenders are involved in various business strategies, such as gaining product approval from regulatory authorities, in order to strengthen their market presence. For instance, in July 2019, Alembic Pharmaceuticals, a leading India-based pharmaceutical company, received the U.S. Food and Drug Administration (FDA) approval for pregabalin capsules, which are indicated for neuropathic pain. In July 2019, InvaGen Pharmaceuticals, a subsidiary company of Cipla Limited, received the FDA approval for its generic version of pregabalin capsules. These capsules are indicated for the management of neuropathic pain associated with certain diseases. Furthermore, BioElectronics Corporation received the U.S. FDA approval for its RecoveryRX device, which is indicated for treatment of post-operative pain, in August 2019. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/154 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
© Coherent market Insights. All Rights Reserved